Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 10/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TOP2A | P11388 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.40 |
| ▸ | PDE1A | P54750 | 2/20 | 0.40 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.40 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15182489 | 0.87 | CYP11B2 (0.52) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL6837344 | 0.81 | NPBWR1 (0.53) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL25521018 | 0.80 | NPBWR1 (0.49) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL6837137 | 0.79 | NPBWR1 (0.51) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL24933626 | 0.78 | NPBWR1 (0.50) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL6837239 | 0.77 | NPBWR1 (0.45) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL30875221 | 0.77 | NPBWR1 (0.49) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL30875225 | 0.77 | NPBWR1 (0.49) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL15182490 | 0.76 | NPBWR1 (0.46) | NPBWR1MCHR1MEN1ALDH1A1KMT2A | |
| SCHEMBL6837345 | 0.72 | NPBWR1 (0.49) | NPBWR1MCHR1MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130210807-A1 | Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. | MERCK SHARP & DOHME CORP. | 2013-08-15 | — | — | US | disclosed |
| WO-2012006760-A1 | TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | MERCK SHARP & DOHME CORP. (US) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210807-A1 | Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. | GRM3, GRM6, GRM1 | NPBWR1 621/4885MCHR1 115/4885MEN1 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.